PropertyValue
?:annLabel
  • Oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-refractory/androgen-independent (e.g., rising psa on anti-androgen therapy or post-orchiectomy); clinical metastases (for use in a medicare-approved demonstration project)
?:annotationFrequency
  • 2 ()
is ?:hasCUIAnnotation of
?:type

Metadata

Anon_0  
expand all